or lack thereof:
1. the preff to AB Global (and other parties), total 62.3m US$, has some "interesting" properties -
On 6 November 2017, as part of the financing for the Aneth assets acquisition, Elk Petroleum Inc. (EPI), a wholly owned- EPI has right to redeem Series A in cash at 1.2 x Liquidation Payment Amount
subsidiary of ELK Petroleum Limited, issued 25,000 Series A preferred stocks at US$1,000 per share and 40,000 Series B preferred stocks at US$1,000 per share. During the year, 5,000 Series B preferred stocks was syndicated by AB Global to other parties resulting in an increase in Series A preferred stocks to 30,000 and a decrease in Series B preferred stocks to 35,000.
note that each of these instruments has DIFFERENT TERMS AND RIGHTS .....
viz:
i. 5% of 8/8ths of the Company’s interest in Madden; and
ii. 5% of 8/8ths of the Company’s interest in Grieve
- Dividend of 15% p.a. paid quarterly (whereby 20% of dividend due can be paid in kind by issuing further Preferred
Stock)
- Redemption at option of the holder at the following term:
- If EPI IPO’s in US, Series A holder to receive redemption amount of Liquidation Payment Amount x 1.18 paid
(at Holder’s election) as either:
i. Cash, or
ii. Shares of Common Stock at 80% IPO Price.
- If Change of Control of Company occurs, holders of Series A has right to require redemption at 1.18 x
Liquidation Payment Amount
- Redemption at option of EPI at the following term:
instrument.
"B"
Fees:
i. 100% Madden net cash flow until Series B shares are re-paid
ii. After Series B has been re-paid, a Net Profit Overriding Royalty Interest (NPI) at Madden of 25% of Madden
net cash
iii. If Series B had been syndicated prior to 6 December 2017, the Madden net cash flow would have been
reduced to 25%
- Dividend of 15% p.a. paid quarterly (whereby 20% of dividend due can be paid in kind by issuing further
Preferred Equity Shares)
- Redemption at option of the holder at the following term:
- If EPI IPO’s in US, Series B holder to receive redemption amount of Liquidation Payment Amount x 1.18 paid
(at Holder’s election) as either:
i. Cash, or
ii. Shares of Common Stock at 80% IPO Price.
- If Change of Control of EPI occurs, holders of Series B has right to require redemption at 1.18 x Liquidation
Payment Amount
- Redemption at option of EPI at the following term:
- EPI has right to redeem Series A in cash at 1.2 x Liquidation Payment Amount
The preferred stock - debt includes transaction costs of US$4.8 million. The dividends for the purposes of the financial
statements are treated as an interest cost / financing costs on the basis the preferred stocks are classified as a debt
this is the 1st time this apprears to have been disclosed !
note that the preff resulted in both int costs to ELK shareholders, and an "impairment loss" of 13.6m (below)
Madden 1P reserves decreased substantially during the year as a result of impact of gas prices and the present value of future cashflows were negatively impacted by the AB Global ORRI & NPI. This led to an impairment trigger resulting in the impairment of Madden by US$13.6 million to a nil carrying value. A future change in 1P reserves or renegotiation of the AB Global ORRI & NPI may result in a reversal of a portion or all of the Madden impairment.
note that the preff holder appears to have the ability to "switch" between Madden+grieve cashflows to Madden only c/flows (and did so during the period under review).
finally - note that to pay these punters out is going to take approx. A$102m !!!!!!!!!!!!!!!!!!!!!!!!!
also note that the "refinancing" has been delayed a second time (from sept to Oct-dec)......lolz .......
once they pay out the contingent consideration (US$10m) for the aneth acq ........their aint going to be much left in the tin......and note that the payables increased a "smidge" ........
imho - this thing aint an investable story until they get rid of the odious structure .........
rgds
V_H
- Forums
- ASX - By Stock
- ELK
- disclosure
disclosure
Featured News
Add ELK (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online